TY - JOUR
T1 - Differential loss of synaptic proteins in Alzheimer's disease
T2 - Implications for synaptic dysfunction
AU - Reddy, P (Hemachandra)
AU - Mani, Geethalakshmi
AU - Park, Byung S.
AU - Jacques, Joline
AU - Murdoch, Geoffrey
AU - Whetsell, William
AU - Kaye, Jeffrey
AU - Manczak, Maria
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2005
Y1 - 2005
N2 - The objective of our research was to determine synaptic protein levels in brain specimens from AD subjects and age-matched control subjects. Further, to determine whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains. Two brain regions - the frontal and parietal cortices - were assessed for protein levels by immunoblotting analysis. We found a loss of both presynaptic vesicle proteins and postsynaptic proteins in all brain specimens from AD patients compared to those from age-matched control subjects. Further, we found that the loss of synaptic proteins was more severe in the frontal cortex brain specimens than in the parietal cortex brain specimens from the AD subjects compared to those from the control subjects, suggesting that the frontal brain may be critical for synaptic function in AD. Using immunohistochemistry techniques, we also determined the distribution pattern of all synaptic proteins in both the frontal and parietal cortices brain specimens from control subjects. Of the 7 synaptic proteins studied, the presynaptic proteins synaptophysin and rab 3A and the postsynaptic protein synaptopodin were the most down-regulated. Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD.
AB - The objective of our research was to determine synaptic protein levels in brain specimens from AD subjects and age-matched control subjects. Further, to determine whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains. Two brain regions - the frontal and parietal cortices - were assessed for protein levels by immunoblotting analysis. We found a loss of both presynaptic vesicle proteins and postsynaptic proteins in all brain specimens from AD patients compared to those from age-matched control subjects. Further, we found that the loss of synaptic proteins was more severe in the frontal cortex brain specimens than in the parietal cortex brain specimens from the AD subjects compared to those from the control subjects, suggesting that the frontal brain may be critical for synaptic function in AD. Using immunohistochemistry techniques, we also determined the distribution pattern of all synaptic proteins in both the frontal and parietal cortices brain specimens from control subjects. Of the 7 synaptic proteins studied, the presynaptic proteins synaptophysin and rab 3A and the postsynaptic protein synaptopodin were the most down-regulated. Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD.
KW - Alzheimer's disease
KW - Cognitive decline
KW - Synaptic protein
KW - Synaptophysin
KW - Synaptopodin
UR - http://www.scopus.com/inward/record.url?scp=17844378691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17844378691&partnerID=8YFLogxK
U2 - 10.3233/JAD-2005-7203
DO - 10.3233/JAD-2005-7203
M3 - Article
C2 - 15851848
AN - SCOPUS:17844378691
SN - 1387-2877
VL - 7
SP - 103
EP - 117
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 2
ER -